These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Indication of an antipsychotic action of the opiate antagonist naloxone. Emrich HM; Cording C; Pirée S; Kölling A; von Zerssen D; Herz A Pharmakopsychiatr Neuropsychopharmakol; 1977 Sep; 10(5):265-70. PubMed ID: 30101 [TBL] [Abstract][Full Text] [Related]
9. Naloxone fails to reverse blood pressure in shock: a double blind study in man. Montastruc JL; Richard JP; Cathala B J Pharmacol; 1985; 16(3):313-4. PubMed ID: 3906280 [No Abstract] [Full Text] [Related]
10. Low- and high-dose naloxone in dementia of the Alzheimer type. Tariot PN; Sunderland T; Weingartner H; Murphy DL; Cohen MR; Cohen RM Psychopharmacol Bull; 1985; 21(3):680-2. PubMed ID: 3898183 [No Abstract] [Full Text] [Related]
11. Naloxone may be beneficial in the treatment of tardive dyskinesia. Blum I; Munitz H; Shalev A; Roberts E Clin Neuropharmacol; 1984; 7(3):265-7. PubMed ID: 6386154 [No Abstract] [Full Text] [Related]
13. Lack of effect of naloxone on selection of nutrients by bulimic women. Soll E; Thomas B; Mitchell JE; Morley J Am J Psychiatry; 1989 Jun; 146(6):803. PubMed ID: 2729436 [No Abstract] [Full Text] [Related]
15. Effects of naloxone in senile dementia: a double-blind trial. Reisberg B; Ferris SH; Anand R; Mir P; Geibel V; De Leon MJ; Roberts E N Engl J Med; 1983 Mar; 308(12):721-2. PubMed ID: 6338389 [No Abstract] [Full Text] [Related]
16. Effect of naloxone on acute stroke. Czlonkowska A; Cyrta B Pharmacopsychiatry; 1988 Mar; 21(2):98-100. PubMed ID: 3293092 [TBL] [Abstract][Full Text] [Related]
17. Double-blind placebo-controlled trial of naloxone on motor deficits in acute cerebrovascular disease. Perraro F; Tosolini G; Pertoldi F; Sbrojavacca R; Beorchia A; Bulfoni A; Del Fabbro L; Grassi L; Lestuzzi A; Mione V Lancet; 1984 Apr; 1(8382):915. PubMed ID: 6143225 [No Abstract] [Full Text] [Related]
18. Intravenous naloxone administration in schizophrenia and affective illness. Davis GC; Bunney WE; DeFraites EG; Kleinman JE; van Kammen DP; Post RM; Wyatt RJ Science; 1977 Jul; 197(4298):74-7. PubMed ID: 325650 [TBL] [Abstract][Full Text] [Related]
19. Relief of intractable pruritus with naloxone. Bernstein JE; Swift R Arch Dermatol; 1979 Nov; 115(11):1366-7. PubMed ID: 389168 [No Abstract] [Full Text] [Related]